Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ahmed Aijaz, MD
Stanford University
Principal Investigator - Arthur Berman, DO
Florida Center for Gastroenterology
Principal Investigator - David Nelson, MD
University of Florida Hepatology
Principal Investigator - Joseph Lim, MD
Yale University Digestive Diseases
Principal Investigator - Ramsey Cheung, MD
VA Palo Alto Health Care System
Principal Investigator - Ronald Pruitt, MD
Nashville Medical Research Institute
Principal Investigator - Stephen Harrison, MD
Brooke Army Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Palo Alto Healthcare System
Palo Alto, California, United States
- Stanford University School of Medicine
Stanford, California, United States
- Yale University Digestive Diseases
New Haven, Connecticut, United States
- University of Florida Hepatology
Gainesville, Florida, United States
- Florida Center for Gastroenterology
Largo, Florida, United States
- Atlanta Gastroenterology Associates
Atlanta, Georgia, United States
- Weill Cornell Medical College
New York, New York, United States
- Nashville Medical Research Institute
Nashville, Tennessee, United States
- Brooke Army Medical Center
Fort Sam Houston, Texas, United States
- Mcguire Va Medical Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2007
- Primary completion
- 28 Feb 2010
- Completion
- 28 Feb 2010
- Last update posted
- 8 May 2014
- Registered enrollment
- 64
- Registry id
- NCT00495391
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.